Tumour cell resistance to non-MHC-restricted lymphocytes molecular mechanisms and clinical implications

Target ArticleEdit

Tumour cell resistance to non-MHC-restricted lymphocytes molecular mechanisms and clinical implications; P Tagliaferri,  Guarrasi, M Caraglia, D Morelliae; 1998; doi_citing_unknown

RetractionEdit

Oligosaccharide Ligands for NKR-P1 Protein Activate NK Cells and Cytotoxicity  ; Karel Bezouska Chun-ting Yuen Jacqui O'Brien Robert A Childs Wengang Chai Karel Drbal Anna Fis; 11/10/1994

https://doi.org/10.1038/372150a0

Citation pieceEdit

Note: Open to append information.